Latest glimepiride Stories
Compared to another popular drug, three widely used diabetes medications are associated with a greater risk of death.
TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia.
Linagliptin (trade name: Trajenta®) has been approved since August 2011 to improve blood glucose control ("glycaemic control") in adults with type 2 diabetes mellitus whose elevated blood glucose levels are inadequately controlled by diet and exercise.
Boehringer Ingelheim and Lilly today announced Phase III study results for linagliptin*, demonstrating improved glycemic control in adults with type 2 diabetes (T2D) whose blood glucose is not adequately controlled on current therapy.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.